Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.19 USD | +5.01% | +6.89% | -34.94% |
Financials (USD)
Sales 2024 * | 20.34M | Sales 2025 * | 71.52M | Capitalization | 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -198M | Net income 2025 * | -138M | EV / Sales 2024 * | 23.9 x |
Net cash position 2024 * | 629M | Net cash position 2025 * | 542M | EV / Sales 2025 * | 8.01 x |
P/E ratio 2024 * |
-4.88
x | P/E ratio 2025 * |
-7.6
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | +5.01% | ||
1 week | +6.89% | ||
1 month | +4.75% | ||
3 months | -32.74% | ||
Current year | -34.94% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Christian Itin
CEO | Chief Executive Officer | 59 | 14-09-30 |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.19 | +5.01% | 1,494,830 |
24-05-30 | 3.99 | -0.75% | 885,826 |
24-05-29 | 4.02 | -.--% | 638,508 |
24-05-28 | 4.02 | +2.55% | 529,920 |
24-05-24 | 3.92 | +1.29% | 511,867 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.94% | 1.11B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AUTL Stock